From the East Kent Hospitals University NHS Foundation Trust, Kent and Canterbury Hospital, Canterbury, Kent, United Kingdom (Kaur, Kopsachilis, Zia); New Hayesbank Ophthalmology Services, Kent, United Kingdom (Kopsachilis, Zia).
J Cataract Refract Surg. 2021 Jun 1;47(6):695-701. doi: 10.1097/j.jcrs.0000000000000510.
To investigate whether phacoemulsification is an aerosol-generating procedure in a live patient environment.
New Hayesbank Ophthalmology Services, Kent, United Kingdom.
In vivo experimental human eyes study.
Aerosol particle counts sized 0.3 μm or lesser, more than 0.3 to 0.5 μm or lesser, more than 0.5 to 1 μm or lesser, more than 1 to 2.5 μm or lesser, more than 2.5 to 5 μm or lesser, and more than 5 to 10 μm or lesser were measured during elective phacoemulsification surgery of 25 eyes. The baseline particle count in the operating theater was measured on 2 separate days to assess for fluctuation. Then, 5 readings each during prephacoemulsification and phacoemulsification of all eyes were measured. The difference in aerosol generation during prephacoemulsification and phacoemulsification was also measured with the use of the mobile laminar air flow (LAF) machine. Finally, aerosol generation during phacoemulsification was measured using 2% hydroxypropyl methylcellulose (HPMC).
There was no statistically significant difference in measurement of aerosol between the baseline measurements on both days and between each patient's prephacoemulsification and phacoemulsification stages of surgery. The LAF system showed statistically significant reduction in particles size of 0.3 μm or lesser, more than 0.3 to 0.5 μm or lesser, more than 0.5 to 1 μm or lesser, more than 1 to 2.5 μm or lesser, more than 2.5 to 5 μm or lesser, and more than 5 to 10 μm during phacoemulsification compared with that during prephacoemulsification (P value .00 for all particle sizes, t test). The use of 2% HPMC did not show any statistically significant reduction in particle measurements.
Aerosol particles sized less than 10 μm are not produced during phacoemulsification of human crystalline lens in a live patient setting. The use of a mobile LAF machine significantly reduced the number of particles sized 10 μm or lesser within the surgical field.
研究在活体患者环境中,超声乳化术是否会产生气溶胶。
英国肯特郡新海斯班克眼科服务处。
体内实验性人眼研究。
在 25 只眼的选择性超声乳化手术中测量 0.3μm 或更小、0.3μm 至 0.5μm 或更小、0.5μm 至 1μm 或更小、1μm 至 2.5μm 或更小、2.5μm 至 5μm 或更小和 5μm 至 10μm 或更小的气溶胶粒子计数。在 2 个不同的日子里测量手术室的基线粒子计数,以评估波动情况。然后,测量所有眼睛在超声乳化术前和超声乳化术中的 5 次读数。还使用移动层流空气(LAF)机测量了超声乳化术前和超声乳化术中气溶胶生成的差异。最后,使用 2%羟丙基甲基纤维素(HPMC)测量超声乳化术中的气溶胶生成。
两天的基线测量值之间以及每位患者的超声乳化术前和超声乳化术阶段之间的气溶胶测量值均无统计学显著差异。LAF 系统显示,与超声乳化术前相比,0.3μm 或更小、0.3μm 至 0.5μm 或更小、0.5μm 至 1μm 或更小、1μm 至 2.5μm 或更小、2.5μm 至 5μm 或更小以及 5μm 至 10μm 范围内的粒子尺寸的统计学显著减少(所有粒子尺寸的 P 值均为.00,t 检验)。使用 2%HPMC 并没有显示出任何粒子测量的统计学显著减少。
在活体患者环境中,超声乳化术不会产生尺寸小于 10μm 的气溶胶颗粒。使用移动 LAF 机可显著减少手术区域内 10μm 或更小粒径的颗粒数量。